Skip to main content
iNtRON Biotechnology, Inc. (KOSDAQ:048530)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,960.00
-75.00 (-1.86%)
May 9, 2025, 1:29 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Immuno-oncology Drugs - Product
6.16B
Log In
Log In
Log In
Log In
Immuno-oncology Drugs - Product Growth
-22.80%
Log In
Log In
Log In
Log In
Technology Transfer
111.65M
Log In
Log In
Log In
Log In
Technology Transfer Growth
-91.46%
Log In
Log In
Log In
Log In
Immuno-oncology Drugs - Service
76.56M
Log In
Log In
Log In
Log In
Immuno-oncology Drugs - Service Growth
-64.89%
Log In
Log In
Log In
Log In
Immuno-oncology Drugs - Merchandise
72.04M
Log In
Log In
Log In
Log In
Immuno-oncology Drugs - Merchandise Growth
-13.50%
Log In
Log In
Log In
Log In
Other
187.00K
Log In
Log In
Log In
Log In
Other Growth
-78.75%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
South Korea
6.42B
Log In
Log In
Log In
Log In
South Korea Growth
-33.05%
Log In
Log In
Log In
Log In